Lonsurf Hits Phase III OS Target In Gastric Cancer Study

 
• By John Davis

An improvement in overall survival seen in the Phase III TAGS study and a unique mechanism of action augurs well for Taiho/Servier's Lonsurf gaining gastric cancer as an additional indication, but future competitive pressures are likely to be intense in this therapeutic sector.  

Helicobacter pylori
H pylori infection may precede the development of stomach cancer • Source: Shutterstock

More from Clinical Trials

More from R&D